ATEC

SEC source: 0001415889-23-003727 · form4-03022023_020316.xml · derivative · entry 4

Lish Scott · CIK 0001831608 · SVP, DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,493 shares

Expires 2023-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-003727 · form4-03022023_020316.xml · nonDerivative · entry 3

Lish Scott · CIK 0001831608 · SVP, DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 441,091

F4 · kind: On March 1, 2023, the reporting person exercised warrants to purchase 13,493 shares of the issuer's common stock for $3.50 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer withholding 2,924 of the warrant shares to pay the exercise price and issuing to the reporting person 10,569 shares.

SEC source: 0001415889-23-003727 · form4-03022023_020316.xml · nonDerivative · entry 2

Lish Scott · CIK 0001831608 · SVP, DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 444,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-003728 · form4-03022023_020340.xml · nonDerivative · entry 2

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,426,851

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.82 to $15.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-003728 · form4-03022023_020340.xml · nonDerivative · entry 1

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,436,789

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.53 to $14.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-003727 · form4-03022023_020316.xml · nonDerivative · entry 1

Lish Scott · CIK 0001831608 · SVP, DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 430,522

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.51 to $14.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes 2,034 shares and 826 shares acquired under the issuer's employee stock purchase plan on May 13, 2022 and November 15, 2022, respectively.

SEC source: 0001415889-23-003726 · form4-03022023_020321.xml · nonDerivative · entry 1

Koning John Todd · CIK 0001830843 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 432,052

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.51 to $14.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-003224 · form4-02242023_010221.xml · nonDerivative · entry 2

Lish Scott · CIK 0001831608 · SVP, DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 453,034

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.23 to $14.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-003227 · form4-02242023_010253.xml · nonDerivative · entry 1

Koning John Todd · CIK 0001830843 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 470,644

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 to $14.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-002960 · form4-02222023_010209.xml · nonDerivative · entry 3

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,472,861

F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.68 to $14.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-003224 · form4-02242023_010221.xml · nonDerivative · entry 1

Lish Scott · CIK 0001831608 · SVP, DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 465,534

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.77 to $14.27, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001567619-23-003444 · doc1.xml · derivative · entry 3

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,346,032 shares

Expires 2023-05-17

F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

SEC source: 0001567619-23-003444 · doc1.xml · nonDerivative · entry 2

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,781,538

F3 · shares: Represents a "cashless exercise" of outstanding warrants. The reporting person received 1,783,705 shares of Common Stock on cashless exercise of warrants to purchase 2,346,032 shares of Common Stock. The Company withheld 562,327 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on February 16, 2023 of approximately $14.60, pursuant to the terms of the warrant.

F4 · balance_after: Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer.

F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

SEC source: 0001567619-23-003444 · doc1.xml · nonDerivative · entry 1

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,343,865

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · balance_after: Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer.

F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

SEC source: 0001415889-23-002960 · form4-02222023_010209.xml · derivative · entry 4

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 134,921 shares

Expires 2023-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-002960 · form4-02222023_010209.xml · nonDerivative · entry 2

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,538,577

F1 · kind: On February 17, 2023, the reporting person exercised warrants to purchase 134,921 shares of the issuer's common stock for $3.50 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer withholding 32,339 of the warrant shares to pay the exercise price and issuing to the reporting person 102,582 shares.

SEC source: 0001415889-23-002960 · form4-02222023_010209.xml · nonDerivative · entry 1

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,570,916

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-23-002296 · form4-02102023_110259.xml · nonDerivative · entry 1

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,435,995

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-001973 · form4-02032023_080201.xml · nonDerivative · entry 3

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,928,117

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F4 · shares: On February 1, 2023, the issuer granted to the reporting person 103,391 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of the grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

F4 · price: On February 1, 2023, the issuer granted to the reporting person 103,391 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of the grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

SEC source: 0001415889-23-001973 · form4-02032023_080201.xml · nonDerivative · entry 2

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,824,726

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F3 · shares: On February 1, 2023, the issuer granted to the reporting person 206,782 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

F3 · price: On February 1, 2023, the issuer granted to the reporting person 206,782 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

SEC source: 0001415889-23-001973 · form4-02032023_080201.xml · nonDerivative · entry 1

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,617,944

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F2 · shares: On February 1, 2023, the issuer awarded 316,311 RSUs to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

F2 · price: On February 1, 2023, the issuer awarded 316,311 RSUs to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

SEC source: 0001415889-23-001977 · form4-02032023_080227.xml · nonDerivative · entry 3

Lish Scott · CIK 0001831608 · SVP, DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475,104

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F4 · shares: On February 1, 2023, the issuer granted to the reporting person 25,041 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of the grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

F4 · price: On February 1, 2023, the issuer granted to the reporting person 25,041 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of the grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

SEC source: 0001415889-23-001977 · form4-02032023_080227.xml · nonDerivative · entry 2

Lish Scott · CIK 0001831608 · SVP, DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,063

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F3 · shares: On February 1, 2023, the issuer granted to the reporting person 50,083 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

F3 · price: On February 1, 2023, the issuer granted to the reporting person 50,083 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

SEC source: 0001415889-23-001977 · form4-02032023_080227.xml · nonDerivative · entry 1

Lish Scott · CIK 0001831608 · SVP, DEVELOPMENT

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 399,980

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F2 · shares: On February 1, 2023, the issuer awarded 76,638 RSUs to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

F2 · price: On February 1, 2023, the issuer awarded 76,638 RSUs to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

SEC source: 0001415889-23-001975 · form4-02032023_080213.xml · nonDerivative · entry 3

Koning John Todd · CIK 0001830843 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 483,712

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F4 · shares: On February 1, 2023, the issuer granted to the reporting person 32,403 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of the grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

F4 · price: On February 1, 2023, the issuer granted to the reporting person 32,403 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of the grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

SEC source: 0001415889-23-001975 · form4-02032023_080213.xml · nonDerivative · entry 2

Koning John Todd · CIK 0001830843 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 451,309

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F3 · shares: On February 1, 2023, the issuer granted to the reporting person 64,806 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

F3 · price: On February 1, 2023, the issuer granted to the reporting person 64,806 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

SEC source: 0001415889-23-001975 · form4-02032023_080213.xml · nonDerivative · entry 1

Koning John Todd · CIK 0001830843 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 386,503

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F2 · shares: On February 1, 2023, the issuer awarded 90,242 RSUs to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

F2 · price: On February 1, 2023, the issuer awarded 90,242 RSUs to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

SEC source: 0001415889-23-001976 · form4-02032023_080218.xml · nonDerivative · entry 3

Sponsel David · CIK 0001772837 · EVP, SALES

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 736,004

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F4 · shares: On February 1, 2023, the issuer granted to the reporting person 30,314 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of the grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

F4 · price: On February 1, 2023, the issuer granted to the reporting person 30,314 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of the grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

SEC source: 0001415889-23-001976 · form4-02032023_080218.xml · nonDerivative · entry 2

Sponsel David · CIK 0001772837 · EVP, SALES

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 705,690

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F3 · shares: On February 1, 2023, the issuer granted to the reporting person 60,629 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

F3 · price: On February 1, 2023, the issuer granted to the reporting person 60,629 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

SEC source: 0001415889-23-001976 · form4-02032023_080218.xml · nonDerivative · entry 1

Sponsel David · CIK 0001772837 · EVP, SALES

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 645,061

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F2 · shares: On February 1, 2023, the issuer awarded 98,078 RSUs to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

F2 · price: On February 1, 2023, the issuer awarded 98,078 RSUs to the reporting person upon confirmation by the issuer's compensation committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

SEC source: 0001415889-23-001974 · form4-02032023_080208.xml · nonDerivative · entry 3

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,495,995

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F4 · shares: On February 1, 2023, the issuer granted to the reporting person 46,175 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

F4 · price: On February 1, 2023, the issuer granted to the reporting person 46,175 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest on the third anniversary of grant date; provided, however, that no portion of such RSUs shall vest unless the publicly-traded stock price for the issuer's common stock at the close of the market on such third anniversary date is equal to or greater than $24 per share (representing a 81% increase in the price per share as of the grant date).

SEC source: 0001415889-23-001974 · form4-02032023_080208.xml · nonDerivative · entry 2

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,449,820

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F3 · shares: On February 1, 2023, the issuer granted to the reporting person 92,349 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

F3 · price: On February 1, 2023, the issuer granted to the reporting person 92,349 RSUs, subject to stockholder approval of an amendment to issuer's 2016 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by an amount sufficient to cover such grant. The RSUs vest in three equal installments on each of the first three anniversaries of the grant date.

SEC source: 0001415889-23-001974 · form4-02032023_080208.xml · nonDerivative · entry 1

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,357,471

F1 · security: Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock.

F2 · shares: On February 1, 2023, the issuer awarded 146,297 RSUs to the reporting person upon confirmation by the issuer's Compensation Committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

F2 · price: On February 1, 2023, the issuer awarded 146,297 RSUs to the reporting person upon confirmation by the issuer's Compensation Committee of satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. The RSUs vest in three equal installments on each of February 24, 2023, February 24, 2024 and February 24, 2025.

SEC source: 0001567619-23-001321 · doc1.xml · derivative · entry 3

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,346,032

Underlying: Common Stock · 2,000,000 shares

Expires 2023-05-17

F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

SEC source: 0001567619-23-001321 · doc1.xml · nonDerivative · entry 2

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,997,833

F3 · shares: Represents a "cashless exercise" of outstanding warrants. The reporting person received 1,467,487 shares of Common Stock on cashless exercise of warrants to purchase 2,000,000 shares of Common Stock. The Company withheld 532,513 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on January 24, 2023 of approximately $13.14, pursuant to the terms of the warrant.

F4 · balance_after: Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer.

F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

SEC source: 0001567619-23-001321 · doc1.xml · nonDerivative · entry 1

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,530,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · balance_after: Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer.

F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

SEC source: 0001415889-23-001409 · form4-01242023_100123.xml · nonDerivative · entry 3

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,301,633

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.89 to $13.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-001409 · form4-01242023_100123.xml · nonDerivative · entry 2

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,361,633

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.99 to $13.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-001409 · form4-01242023_100123.xml · nonDerivative · entry 1

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,421,633

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.94 to $13.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-001235 · form4-01202023_010155.xml · nonDerivative · entry 3

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,481,633

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.10 to $13.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-001235 · form4-01202023_010155.xml · nonDerivative · entry 2

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,541,633

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.98 to $13.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-001235 · form4-01202023_010155.xml · nonDerivative · entry 1

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,601,633

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.90 to $13.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-23-000718 · form4-01102023_080142.xml · nonDerivative · entry 1

Hunsaker Craig E · CIK 0001509282 · EVP, PEOPLE/CULTURE & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,211,174

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2022.

SEC source: 0001415889-23-000716 · form4-01102023_080142.xml · nonDerivative · entry 1

Sponsel David · CIK 0001772837 · EVP, SALES

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 546,983

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.57 to $12.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-24-003616 · form5-02132024_110232.xml · nonDerivative · entry 1

TULLIS JAMES L L · CIK 0001230641 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,618

SEC source: 0001415889-22-012805 · form4-12202022_031218.xml · nonDerivative · entry 1

TULLIS JAMES L L · CIK 0001230641 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Tullis Growth Fund, L.P.

Disclosed balance after: 497,974

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.20 to $10.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001415889-22-012080 · form4-12052022_111222.xml · nonDerivative · entry 1

Sponsel David · CIK 0001772837 · EVP, SALES

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 556,983

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2022.

F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.73 to $10.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3 · balance_after: Includes 293 shares acquired under the issuer's employee stock purchase plan on November 15, 2022.

SEC source: 0001567619-22-020632 · doc1.xml · derivative · entry 3

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,346,032

Underlying: Common Stock · 1,000,000 shares

Expires 2023-05-17

F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

SEC source: 0001567619-22-020632 · doc1.xml · nonDerivative · entry 2

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,530,345

F3 · shares: Represents a "cashless exercise" of outstanding warrants. The reporting person received 663,375 shares of Common Stock on cashless exercise of warrants to purchase 1,000,000 shares of Common Stock. The Company withheld 336,625 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on November 16, 2022 of approximately $10.40, pursuant to the terms of the warrant.

F4 · balance_after: Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer.

F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

SEC source: 0001567619-22-020632 · doc1.xml · nonDerivative · entry 1

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,866,970

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · balance_after: Paul Segal separately is the direct beneficial owner of 338,825 shares of Common Stock of the Issuer.

F1 · ownership.direct: Each of Andy Barnett and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.